If you are a beauty brand watching the "salmon DNA" boom and wondering what you can realistically put on your own shelf, the short answer is this: PDRN and PN are DNA-derived ingredients that have moved from Korean aesthetic clinics into mainstream topical skincare, and an experienced OEM can build them into serums, ampoules, creams, sheet masks, and at-home microinfusion kits — as cosmetics. What a private-label brand cannot do is sell an injectable "skin booster" as a cosmetic, or copy clinical, regenerative-medicine claims on a topical bottle.
This guide explains what PDRN and PN are, how they differ, which finished formats make sense for an export-focused brand, how to formulate responsibly, and where the regulatory line sits. It is written for brand owners, importers, and distributors who want to launch a credible salmon-DNA line without overclaiming.
What PDRN is — the 30-second answer
PDRN (polydeoxyribonucleotide) is a mixture of short, highly purified DNA fragments, most commonly extracted from the sperm or milt of salmon or trout such as chum salmon (Oncorhynchus keta) or rainbow trout (Oncorhynchus mykiss). During purification, proteins, lipids, and cellular debris are removed, leaving water-soluble DNA fragments. On cosmetic ingredient lists it usually appears as Sodium DNA, and the material is often marketed as "salmon DNA." PDRN does not change a person's own DNA; the fragments are too small to carry genetic information, and the ingredient is a topical cosmetic input, not a gene therapy.
PDRN fragments are generally described as smaller molecules, often cited in the range of tens to around 1,500 kDa depending on the supplier and grade. In ingredient research, PDRN has been studied for its interaction with adenosine A2A receptors and as a source of nucleotide fragments through the cellular "salvage" pathway. That clinical heritage — the ingredient was originally used in wound-care research before Korean brands adapted it for topical cosmetics — is part of why it feels more credible than a typical trend-driven active.
PDRN vs PN: a practical distinction
PN (polynucleotide) and PDRN are related but not identical, and the terms are used loosely in marketing. In general, PN refers to longer-chain, larger DNA fragments, while PDRN refers to shorter, more fragmented, more highly purified chains. Common supplier descriptions place PDRN at the smaller end and PN at the larger end, sometimes extending to several thousand kDa, with PN showing more gel-like, viscoelastic behavior.
For a topical private-label product this difference is usually less dramatic than marketing charts suggest. Both are salmon- or trout-derived DNA fragments, both are used for hydration and the appearance of skin recovery, and many finished formulas use a blend. What matters more to your brand is supplier transparency: a reputable manufacturer should be able to tell you the source, the INCI name, the molecular-weight profile, and the concentration. If a supplier only says "salmon extract" and cannot specify the DNA content or molecular weight, you are not buying a well-characterized ingredient.
A labeling note: in many K-beauty cosmetics, the INCI you will actually see is Sodium DNA. "PDRN" and "polynucleotide" are often marketing or technical names rather than the exact INCI string. Your OEM should confirm the precise INCI used in your target market rather than assuming "PDRN" will appear word-for-word on the back of the pack.
Why brands are launching salmon DNA now
The category is being pulled by three things at once. First, K-beauty has normalized it: well-known Korean brands have brought PDRN serums, essences, and balms into mainstream retail, so consumers and retailers already understand the basic story. Second, it has a clinical and research backstory that many trendy ingredients lack, which suits "medi-beauty" and science-positioned brands. Third, it fills a gap in a routine between simple hydration and heavier anti-aging actives — it is positioned around the look of smooth, hydrated, comfortable, recovered skin rather than around exfoliation or strong actives.
For an export brand, that makes it a useful premium or "clinically inspired" line rather than a budget one. It pairs naturally with a story about clean, controlled manufacturing and traceable active sourcing.
Finished formats an OEM can build for you
A capable cosmetic OEM can place PDRN/PN into several topical formats, each with a different role and price point:
PDRN serums and ampoules are the most common entry point — lightweight, water-based products that let the ingredient be the hero and are easy to merchandise as a daily "recovery" or hydration step. Clear ampoules in vials or dropper bottles communicate a clinical feel and are a natural fit for brands that want a premium, medi-beauty look.
Creams and moisturizers combine the ingredient with emollients and occlusives, suiting drier or more mature skin and giving a richer sensorial experience. Because nucleotide chains are water-soluble, the cream still has to be formulated to keep the active stable and evenly dispersed.
Sheet masks and eye patches are popular because the occlusive, damp environment of a mask supports hydration and helps water-soluble actives stay in contact with the skin. PDRN eye products in particular ride the "under-eye recovery" positioning the ingredient is known for.
At-home microinfusion or "micro-needling-style" kits are where the trend is heading for premium brands: a handheld applicator with a micro-structure tip is paired with PDRN ampoules so the consumer applies the serum at home. This is a format we can assemble — vials, applicator heads, and inserts packed into a kit — but it is also the format with the sharpest compliance edge, which is covered below. If your kit uses a cosmetic micro-structure applicator, it must be designed and labeled as a cosmetic home-use device, and the serum must remain a cosmetic.
Formulation realities your brand should know
Large DNA fragments do not pass easily through intact skin; the skin barrier limits most very large molecules. In practice, topical PDRN works mainly at the surface and outer layers, which is exactly why responsible positioning is about hydration, comfort, and the appearance of smooth, recovered skin rather than deep clinical results. Formulators address delivery in legitimate ways — lower-molecular-weight fragments, liposomal or encapsulation systems, and supporting ingredients such as propanediol and niacinamide — rather than by promising needle-like penetration from a bottle.
Concentration depends on the raw form. Suppliers commonly describe powder grades used at a fraction of a percent, and liquid PDRN solutions added at a much higher percentage because the solution itself is dilute. This is an easy place for marketing to mislead: "50% PDRN solution" on a label can sound enormous while still delivering a modest amount of active. Your OEM should translate the raw-material spec into the real active content so your claims match the formula.
Compatibility matters. Water-soluble nucleotide chains are generally used in water-based phases and are sensitive to very acidic conditions; combining them directly with strong acids or high-concentration, low-pH vitamin C can compromise stability. PDRN is commonly paired with sodium hyaluronate (for a dual hydration story — immediate surface hydration plus the look of plump, recovered skin), peptides, and calming ingredients. As always, stability and compatibility testing on the finished formula is what confirms a pairing works, not the ingredient chart alone.
The compliance line: cosmetic topical, not an injectable
This is the section that protects your brand. The PDRN/PN used in aesthetic clinics is often delivered by injection and, in professional markets, is regulated as a medical device or medicinal product — in Europe, for example, some professional polynucleotide products carry CE marks as medical devices. That has nothing to do with a topical cosmetic sold to consumers. The two are different product categories with different rules, and a private-label cosmetic cannot borrow the claims, the "skin booster" language, or the regenerative-medicine positioning of an injectable.
Concretely, for an export-facing topical line:
• Position the product as a cosmetic that helps skin look and feel hydrated, smooth, refreshed, and comfortable — and supports the appearance of a healthy, recovered complexion.
• Do not claim the product regenerates tissue, heals wounds, treats scarring, remodels collagen, or produces the effects of an injection. The A2A receptor and collagen-synthesis story belongs in scientific background, not in consumer-facing cosmetic claims.
• Do not market a home-use microinfusion kit as equivalent to a clinic injection, and do not describe the applicator as driving the serum into the dermis. A cosmetic applicator supports surface application; that is the honest claim.
• Remember that no PDRN/PN injectable is approved as a cosmetic, and that exosome and other "regenerative" injectables face even stricter enforcement in the US and Europe. Keep your topical line firmly topical.
• Label for the source. Because the ingredient is fish-derived, products sold into markets that require allergen or source disclosure should be checked with your regulatory partner, and consumers with fish allergies are a recognized caution group.
• Use the correct ingredient and registration path for each destination market. The ingredient appears in cosmetic ingredient inventories (for example, it is listed under polydeoxyribonucleotide / Sodium DNA in China's existing-cosmetic-ingredient inventory, and a Chinese group standard for cosmetic-grade PDRN was issued in 2026), but "listed as an ingredient" is not the same thing as a finished-product registration in the EU, UK, US, or Middle East. Plan the CPNP, safety, and product-information requirements for each region you sell into.
A good OEM will tell you this up front. A supplier who encourages you to use clinical, injectable-style claims on a topical cosmetic is increasing your legal and marketplace risk to make a quicker sale.
How an OEM partnership usually works
A typical private-label salmon-DNA project starts with choosing the format and positioning — an entry serum is the lowest-risk first SKU, with a cream or mask added once the hero product is validated. The OEM then proposes the formula, the Sodium DNA/PDRN grade and concentration, the delivery system, packaging, and the claim set, and supplies samples for evaluation before scale-up. Stability, compatibility, and preservative-efficacy testing support the finished product, and documentation (ingredient specs, safety information, and market-specific paperwork) is prepared for registration and export.
For brands that want confidentiality, an OEM should be willing to work under an NDA and should keep your formula, pricing, and packaging private. Your brand identity is yours; the manufacturer is the manufacturing partner behind it.
Frequently asked questions
Q: What is the difference between PDRN and PN in a cosmetic? A: Both are purified salmon- or trout-derived DNA fragments. PDRN generally describes shorter, more highly purified chains, while PN describes longer chains with more gel-like behavior. In a topical cosmetic the difference is usually modest; supplier transparency on source, INCI (often Sodium DNA), molecular weight, and real active content matters more than the name.
Q: Can I sell a PDRN serum as a cosmetic for export? A: Yes. A topical PDRN/PN serum, ampoule, cream, or mask can be manufactured and sold as a cosmetic, with cosmetic claims about hydration and the appearance of smooth, comfortable, refreshed skin. It must meet the cosmetic regulations and registration requirements of each destination market.
Q: Can I sell a PDRN "skin booster" injection as a private-label cosmetic? A: No. Injectable PDRN/PN products used in clinics are regulated as medical devices or medicinal products, not cosmetics. A private-label cosmetic cannot be sold as an injectable or use clinical, regenerative, or wound-healing claims.
Q: Does topical PDRN work like the clinic injection? A: No, and it should not be marketed that way. The skin barrier limits penetration of large DNA fragments, so a topical product mainly supports the surface and outer layers through hydration and the appearance of smooth, recovered skin. Encapsulation and lower-molecular-weight grades can support delivery, but a cosmetic serum is not an injection.
Q: What product format should we launch first? A: A PDRN serum or ampoule is the most common and lowest-risk first SKU because it makes the ingredient the hero and is easy to position. Once it is validated, brands typically add a cream, sheet mask, eye product, or an at-home microinfusion kit.
Q: Can we make an at-home PDRN microinfusion kit? A: Yes, a cosmetic kit pairing a home-use micro-structure applicator with PDRN ampoules can be assembled, but both the applicator and the serum must be designed, positioned, and labeled as cosmetics for surface application — not as a needle, an injection, or a clinic-equivalent treatment.
Q: What claims are safe to use on a topical PDRN product? A: Use cosmetic, appearance-based language: helps skin look and feel hydrated, smooth, plump, refreshed, and comfortable, and supports the look of a healthy, recovered complexion. Avoid claims about tissue regeneration, wound healing, collagen remodeling, scar treatment, or injectable-level results.
Q: Is PDRN safe, and do we need allergy warnings? A: Purified PDRN removes proteins during processing and is generally used in topical cosmetics, but it is fish-derived. Markets with source- or allergen-disclosure rules should be checked with your regulatory partner, and people with a known fish allergy are a recognized caution group.
Q: What is the INCI name, and will it say "PDRN" on the label? A: The ingredient is commonly listed as Sodium DNA, with PDRN or polydeoxyribonucleotide used as a technical or marketing name. Your OEM should confirm the exact INCI and labeling accepted in each target market.
Q: Can you keep our formula and project confidential? A: Yes. An OEM can work under an NDA and keep your formula, concentration, packaging, and pricing private. Your brand and customer relationships remain yours.
Ready to build a salmon-DNA line?
PDRN/PN is a credible, clinically rooted ingredient that brands can build into a strong premium topical range — serums, ampoules, creams, masks, eye products, and at-home kits — as long as the product stays a cosmetic and the claims stay honest. If you are planning an export-focused private-label line, tell us your target market, preferred format, and positioning, and our team can recommend a formula, packaging, and a market-appropriate claim set, with samples to evaluate before scale-up.